CRISPR/Cas9 genome editing is used to introduce a AATto GAT resulting in an N22D amino acid substitution in exon 6. In humans, the N22D substitution is associated with amyotrophic lateral sclerosis. (J:101977)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count